MedTrace Logo

Safety and Performance of Altura Endograft in Abdominal Aortic Aneurysm (AAA) Endovascular Repair

NCT01991756 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-01-15

No results posted yet for this study

Summary

The primary objective of the study is to evaluate the acute safety of deploying and implanting the Altura Endograft in the treatment of AAA in subjects who are candidates for endovascular repair.

Secondary objectives are to evaluate the acute and longer-term safety and performance of the Altura Endograft through 5 years.

Conditions

  • Abdominal Aortic Aneurysms

Interventions

DEVICE

Altura Endograft System

Subjects with a documented untreated, unruptured, infrarenal abdominal aorto-iliac aneurysm.

Sponsors & Collaborators

  • Altura Medical Inc.

    lead INDUSTRY

Principal Investigators

  • Dierk Scheinert, MD, PhD · Park-Krenkenhaus Leipzig

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01991756 on ClinicalTrials.gov